https://www.avanza.se/placera/redaktionellt/2014/06/25/neurovive-arets-kursvinnare.html
NeuroVive year's winner
Kl. 12:38, June 25, 2014
Stock market research company NeuroVive is the company that did best on the Stockholm Stock Exchange (OMX NASDAQ Stockholm) since year-end.
On the Small Cap list is NeuroVive that tops the winning group with an increase of 171 percent.
The company develops products for the treatment of acute heart and nerve cell damage by mitochondrial protection. During early summer, NeuroVive signed new agreements while insiders have been frequent buyers of shares.
Tomas Linnala tomas.linnala @ placera.nu
(Translated from Swedish)
Disclosure: The author is long NEVPF.
Additional disclosure: Maas Biolab is the largest single owner of NeuroVive Pharmaceutical stock holding about 13%.